| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2013 | US8410086 Compositions and methods for lowering triglycerides |
| 04/02/2013 | US8410085 Phospholipid compositions and uses thereof |
| 04/02/2013 | US8410084 Alkylated heterocyclic reaction products useful as antioxidants |
| 04/02/2013 | US8410083 23-substituted bile acids as TGR5 modulators and methods of use thereof |
| 04/02/2013 | US8410082 Fluorinated diaryl urea derivatives |
| 04/02/2013 | US8410081 Treatment of cystic fibrosis |
| 04/02/2013 | US8410080 2-methylene-vitamin D analogs and their uses |
| 04/02/2013 | US8410079 Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion |
| 04/02/2013 | US8410078 Composition and methods to treat cardiac diseases |
| 04/02/2013 | US8410077 Sulfoalkyl ether cyclodextrin compositions |
| 04/02/2013 | US8410076 Cationized hyaluronic acid and/or salt thereof, method of producing the same, hair modifying agent, cuticle repairing agent, skin modifying agent, and cosmetic preparation each using the same |
| 04/02/2013 | US8410075 Mannich base N-oxide drugs |
| 04/02/2013 | US8410074 Modulation of eIF4E expression |
| 04/02/2013 | US8410073 Methods and compositions for prevention or treatment of RSV infection |
| 04/02/2013 | US8410066 Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors |
| 04/02/2013 | US8410065 Macrolides and their use |
| 04/02/2013 | US8410064 Classical cannabinoid metabolites and methods of use thereof |
| 04/02/2013 | US8410063 N-acetyl mannosamine as a therapeutic agent |
| 04/02/2013 | US8410053 Methods for treating autoimmune disorders, and reagents related thereto |
| 04/02/2013 | US8410052 Oral administration of a calcitonin |
| 04/02/2013 | US8410047 Counteracting drug-induced obesity using GLP-1 agonists |
| 04/02/2013 | US8410026 Pyridazine fungicides |
| 04/02/2013 | US8410024 Use of maleimide salts to control phytopathogenic fungi |
| 04/02/2013 | US8410023 Compositions and methods for controlling nematodes |
| 04/02/2013 | US8409635 Modified pectins, compositions and methods related thereto |
| 04/02/2013 | US8409630 Adding bromine chloride to overbased, aqueous alkali metal sulfamate solution formed from water, sulfamic acid and alkali metal base, wherein pH of sulfamate solution is such that pH of resulting biocidal composition is 7 |
| 04/02/2013 | US8409619 Oral drug delivery system for azole, moxifloxacin and rifampicin |
| 04/02/2013 | US8409618 Fiber substrate with odor absorbent |
| 04/02/2013 | US8409617 Vitamin powder composition and method of making |
| 04/02/2013 | US8409616 Extended release opioid abuse deterrent compositions and methods of making same |
| 04/02/2013 | US8409613 Gastric retained gabapentin dosage form |
| 04/02/2013 | US8409612 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 04/02/2013 | US8409610 Wound care device |
| 04/02/2013 | US8409607 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
| 04/02/2013 | US8409606 Drug delivery through hydrogel plugs |
| 04/02/2013 | US8409600 Methods for prevention and/or treatment of capsular contracture |
| 04/02/2013 | US8409596 Deodorant compositions |
| 04/02/2013 | US8409595 Method for decreasing sebum production |
| 04/02/2013 | US8409594 Solid oil-in-water emulsion |
| 04/02/2013 | US8409593 Methods for reducing tackiness associated with a xanthine compound |
| 04/02/2013 | US8409578 Methods for treating bone loss with antibodies to OPGL |
| 04/02/2013 | US8409574 Taxane analogs for the treatment of brain cancer |
| 04/02/2013 | US8409566 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 04/02/2013 | US8409561 Methods and compositions for treatment of ion imbalances |
| 04/02/2013 | US8409559 Functionalized drugs and polymers derived therefrom |
| 04/02/2013 | US8409558 Method for treatment of onychomycosis |
| 04/02/2013 | US8409557 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
| 04/02/2013 | US8409556 Topical formulations for the prevention of sexually transmitted disease and methods of producing the same |
| 04/02/2013 | US8409552 Anthranillic acid amides and derivatives thereof as cosmetic and pharmaceutical active compounds |
| 04/02/2013 | US8409550 Method for treating skin with retinoids and retinoid boosters |
| 04/02/2013 | US8409549 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 04/02/2013 | CA2728541C Crystalline forms of thiazolidinedione compound and its manufacturing method |
| 04/02/2013 | CA2723222C Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 04/02/2013 | CA2715143C Novel phenylpyrrole derivative |
| 04/02/2013 | CA2702032C Skin property-improving therapeutic agent comprising a morphinan derivative or any of its pharmacologically permissible acid addition salts as an active ingredient |
| 04/02/2013 | CA2642130C Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 04/02/2013 | CA2632067C Method for improving absorbability of epigallocatechin gallate, foods, drinks and food/drink materials using the same and method for producing the same |
| 04/02/2013 | CA2616373C Octahydroisoquinoline compounds as opioid receptor modulators |
| 04/02/2013 | CA2611727C Adhesive preparation |
| 04/02/2013 | CA2602247C Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 04/02/2013 | CA2595544C Compounds having analgesic and/or immunostimulant activity |
| 04/02/2013 | CA2592388C Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 04/02/2013 | CA2588410C 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses |
| 04/02/2013 | CA2585654C Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction |
| 04/02/2013 | CA2585642C Carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof |
| 04/02/2013 | CA2584259C Imidazo-benzodiazepine derivatives |
| 04/02/2013 | CA2567489C Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor |
| 04/02/2013 | CA2566648C Guanylhydrazone salts, compositions, processes of making and methods of using |
| 04/02/2013 | CA2565683C Substituted azepine derivatives as serotonin receptor modulators |
| 04/02/2013 | CA2565424C Macromolecule-containing sustained release intraocular implants and related methods |
| 04/02/2013 | CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 04/02/2013 | CA2563167C Use of flibanserin in the treatment of premenstrual and other female sexual disorders |
| 04/02/2013 | CA2561281C Pharmaceutical composition comprising a salt of mirtazapine |
| 04/02/2013 | CA2556089C Method for enhancing the bioavailability of ospemifene |
| 04/02/2013 | CA2553895C Use of 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, for the preparation of medication useful for the treatment of illnesses linked to pathological choroidal angiogenesis |
| 04/02/2013 | CA2553387C Piperidinyl prostaglandin e analogs |
| 04/02/2013 | CA2550843C Novel phenylalanine derivatives |
| 04/02/2013 | CA2537292C 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/02/2013 | CA2533594C Compounds for inflammation and immune-related uses |
| 04/02/2013 | CA2531759C Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors |
| 04/02/2013 | CA2524603C Controlled release composition containing a strontium salt |
| 04/02/2013 | CA2514948C Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament |
| 04/02/2013 | CA2514327C Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 04/02/2013 | CA2513881C Immunomodulatory compositions |
| 04/02/2013 | CA2512730C Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 04/02/2013 | CA2512108C Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 04/02/2013 | CA2503557C Osteogenesis promotor containing .beta.-cryptoxanthin as the active ingredient |
| 04/02/2013 | CA2496565C Non-nucleoside reverse transcriptase inhibitors |
| 04/02/2013 | CA2491724C Ciclesonide-containing sterile aqueous suspension |
| 04/02/2013 | CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3 |
| 04/02/2013 | CA2472647C Mammal prolactin variants |
| 04/02/2013 | CA2471145C Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 04/02/2013 | CA2470920C Liposomal delivery of vitamin e based compounds |
| 04/02/2013 | CA2457611C Novel molecular target for neurotoxicity |
| 04/02/2013 | CA2452529C Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 04/02/2013 | CA2201282C Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 03/29/2013 | CA2849336A1 Cyanomethylpyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | WO2013044251A1 Anti-stretch mark skin cream and method for making and using thereof |
| 03/28/2013 | WO2013044246A1 Buffered upper gi absorption promoter |
| 03/28/2013 | WO2013044219A1 Methods of treating cancers with therapeutic nanoparticles |